Unusual progression of renal cell carcinoma with carcinomatosis peritoneii and Krukenberg tumour and alopecia with sunitinib therapy in young female

BACKGROUND: Sunitinib is a multiple receptor tyrosine kinase inhibitor (TKI) used for the treatment of renal cell carcinoma (RCC). It increases the median survival considerably with minimum side effects. Alopecia is one of the rare side effects. Metastasis to the ovary is also rare. We report a case...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandey, Manoj, Ramasamy, Mahendran, Shukla, Mridula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801678/
https://www.ncbi.nlm.nih.gov/pubmed/29409504
http://dx.doi.org/10.1186/s12957-018-1328-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801678/
https://www.ncbi.nlm.nih.gov/pubmed/29409504
http://dx.doi.org/10.1186/s12957-018-1328-3

Ejemplares similares